saha et al (2012) sfn and erucin from fresh frozen broccoli (mnfr) (published)
TRANSCRIPT
1906 Mol. Nutr. Food Res. 2012, 56, 1906–1916DOI 10.1002/mnfr.201200225
RESEARCH ARTICLE
Isothiocyanate concentrations and interconversion
of sulforaphane to erucin in human subjects after
consumption of commercial frozen broccoli compared
to fresh broccoli
Shikha Saha1, Wendy Hollands1, Birgit Teucher1, Paul W. Needs1, Arjan Narbad1,Catharine A. Ortori2, David A. Barrett2, John T. Rossiter3, Richard F. Mithen1 and Paul A. Kroon1
1 Institute of Food Research, Norwich Research Park, Norwich, UK2 Centre for Analytical Bioscience, School of Pharmacy, University of Nottingham, Nottingham, UK3 Department of Life Sciences, Division of Cell & Molecular Biology, Sir Alexander Fleming Building, Imperial
College, London, UK
Scope: Sulforaphane (a potent anticarcinogenic isothiocyanate derived from glucoraphanin)
is widely considered responsible for the protective effects of broccoli consumption. Broccoli
is typically purchased fresh or frozen and cooked before consumption. We compared the
bioavailability and metabolism of sulforaphane from portions of lightly cooked fresh or frozen
broccoli, and investigated the bioconversion of sulforaphane to erucin.
Methods and results: Eighteen healthy volunteers consumed broccoli soups produced from
fresh or frozen broccoli florets that had been lightly cooked and sulforaphane thio-conjugates
quantified in plasma and urine. Sulforaphane bioavailability was about tenfold higher for the
soups made from fresh compared to frozen broccoli, and the reduction was shown to be due to
destruction of myrosinase activity by the commercial blanching-freezing process. Sulforaphane
appeared in plasma and urine in its free form and as several thio-conjugates forms. Erucin
N-acetyl-cysteine conjugate was a significant urinary metabolite, and it was shown that human
gut microflora can produce sulforaphane, erucin, and their nitriles from glucoraphanin.
Conclusion: The short period of blanching used to produce commercial frozen broccoli destroys
myrosinase and substantially reduces sulforaphane bioavailability. Sulforaphane was converted
to erucin and excreted in urine, and it was shown that human colonic flora were capable of this
conversion.
Keywords:
Broccoli / Erucin / Sulforaphane
Received: April 20, 2012
Revised: August 22, 2012
Accepted: August 28, 2012
1 Introduction
Epidemiological studies indicate that the consumption of
broccoli is associated with the reduction in the risk of de-
generative disease such as cancer [1]. 4-Methylsulphinylbutyl
glucosinolate (glucoraphanin) accumulates in the florets of
broccoli. Following consumption, it is hydrolysed into the
corresponding isothiocyanate (sulforaphane) either by the
Correspondence: Dr. Paul Kroon, Institute of Food Research,
Colney Lane, Norwich NR4 7UA, UK
E-mail: [email protected]
Fax: +44-1603-507723
Abbreviations: ESP, epithiospecifier like proteins; ITC, isothio-
cyanate
plant thioglucosidase myrosinase or by bacterial thioglu-
cosidases in the colon, if the myrosinase has been dena-
tured by cooking [2]. A nitrile derivative of the glucosino-
late may also be produced due to the interaction of plant
“epithiospecifier-like” proteins (ESP). Mild cooking can de-
nature these proteins but leave myrosinase enzymes intact,
maximising the amount of glucosinolate conversion to isoth-
iocyanate. Following absorption, sulforaphane is conjugated
with glutathione and metabolised via the mercapturic acid
pathway, resulting in predominantly N-acetyl-cysteine conju-
gates that are excreted in the urine [3]. Several studies have
quantified the pharmacokinetics of sulforaphane following
the consumption of broccoli with either active or inactive my-
rosinase. Most of these studies have analysed sulforaphane
and its thiol metabolites in plasma and urine through a
C© 2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim www.mnf-journal.com
Mol. Nutr. Food Res. 2012, 56, 1906–1916 1907
cyclocondensation reaction [4, 5]. While this method is ef-
ficient at quantifying total thiols, it is not able to discriminate
between free isothiocyanates and individual thiol metabo-
lites, or between different isothiocyanates. LC-MS/MS meth-
ods have been developed that are able to distinguish be-
tween different metabolites, and have demonstrated that un-
conjugated sulforaphane is found in the plasma [6]. Analyses
through both approaches have shown that between 30 and
80% of sulforaphane is absorbed into the blood stream or
excreted in the urine compared to the level of the parent glu-
cosinolate if broccoli is consumed with active myrosinase,
but this drops to 10% or less if broccoli is consumed with
inactive myrosinase, with a later Tmax associated with colonic
absorption as opposed to absorption through the stomach or
small intestine [7].
An important question is the fate of the isothiocyanate
or glucosinolate that is not absorbed. One possibility is that
it is not absorbed but excreted in the faeces. Alternatively,
there may be alternative routes to metabolism of sulforaphane
post absorption, and conjugation with proteins has been pro-
posed [4]. A third possibility may be represented by the bio-
conversion of sulforaphane to other isothiocyanates. Recent
studies carried out in humans and rats have reported the in
vivo interconversion of sulforaphane to erucin [8]. The erucin
is the enzymatic hydrolysis product of glucoerucin, mainly
found in rocket salad species, and structurally represents
the reduced analogue of sulforaphane [8]. It was suggested
that the conversion of glucoraphanin/sulforaphane to the re-
duced glucosinolate/isothiocyanate occurred in the liver, and
that there was enterohepatic circulation of glucosinolates so
that hydrolysis occurred via gut microbes [9]. Another study
has confirmed the in vivo interconversion of sulforaphane to
erucin suggesting an inter-subject variability [10].
In the current study, we quantified sulforaphane
metabolism following consumption of soups containing
mildly cooked broccoli (i.e. with active myrosinase, but in-
active ESP) and frozen broccoli with inactivated myrosinase,
and analysed a subset of samples for the presence of erucin
and its thiol conjugates. In addition, we investigated whether
this conversion could be due to gut microbial activity.
2 Materials and methods
2.1 Materials
Sinigrin was obtained from Sigma Chemicals (UK). Sul-
foraphane was obtained from LKT Laboratories, Inc. (Min-
nesota, USA). Methyl-, ethyl- and butyl-isothiocyanates,
cysteine, cysteine-glycine, glutathione and N-acetyl-cysteine
were purchased from Aldrich (UK). DEAE Sephadex A25 and
SP Sephadex C25 were obtained from Amersham Biosciences
(Sweden). The synthesis of cysteine, cysteine-glycine, glu-
tathione and N-acetyl-cysteine conjugates of sulforaphane
was done by an optimized protocol published elsewhere [3].
The synthetic products were purified by preparative HPLC
using a C18 column and the structures of the synthesized ma-
terials were confirmed by 1H NMR (JEOL, EX 270) and LC–
MS–MS (Quattro Ultima tandem mass, Waters Micromass,
Manchester, UK). Sulforaphane-nitrile was synthesized by
the published protocol [11]. All solvents and other chemi-
cals used were of HPLC grade and purity was assessed to be
95% or greater in all compounds. Sulfatase (Type H-1 from
Helix pomatia) was obtained from Sigma Chemicals and pu-
rified before use. Sulfatase (300 mg) was dissolved in ice-cold
water (12 mL), mixed with ice-cold ethanol (12 mL) and
stirred. Following centrifugation (3000 × g, 6 min) the su-
pernatant was mixed with ice-cold ethanol (1.5 × vol), stirred
and centrifuged to obtain a pellet that was dissolved in water
(8 mL). Samples (2 mL) were passed sequentially through
columns of Sephadex A25 and Sephadex C25 to obtain the
purified sulfatase that was stored at −20�C.
2.2 Subjects and study design
Eighteen apparently healthy volunteers aged 20–65 years were
recruited by study scientists to participate in this study, which
was conducted at the Human Nutrition Unit at the Institute
of Food Research. All study participants were assessed for
eligibility on the basis of a health questionnaire and the re-
sults of clinical laboratory tests. All volunteers were screened
for full blood count, fasting glucose, liver function and urea
and electrolytes. The following exclusions applied: smokers;
diagnosed with long-term medical conditions such as asthma
(unless untreated within the past 2 years), heart disease,
gastro-intestinal disease, diabetes, cancer; regular prescribed
medication (except HRT and oral contraceptive); taking di-
etary supplements (unless judged not to affect study out-
come) or antibiotics for greater than 4 weeks before the start
of the study; pregnant; blood donation within 4 months prior
to start of study; BMI less than 18.5 or greater than 35; clin-
ical results at screening judged by the medical advisor to
affect study outcome or be indicative of a health problem.
Subjects were genotyped for the GSTM1 and GSTT1 alleles
but remained blind to the test results. Genomic DNA was
isolated from whole blood samples (200 �L) using a Gene-
lute genomic DNA mini-prep kit (Sigma-Aldrich). GSTM1
and GSTT1 genotypes were identified by quantitative real-
time PCR (Taqman R©) on a 7500 real-time PCR system (Ap-
plied Biosytems, Warrington, UK). Amplification reactions
(25 �L) contained Taqman R© Universal Master Mix, genomic
DNA (50 ng), forward and reverse primers (500 ng each),
a dye-labelled TaqMan R© probe with 3′TAMRA and 5′-FAM
dye-labels (see Gasper et al. for primer and probe sequencess
[16]) and Amplitaq Gold R© DNA polymerase enzyme (Applied
Biosystems). Following activation of the DNA polymerase (10
min at 95�C), reaction mixtures were subjected to 40 PCR cy-
cles, each consisting of 95�C for 15 s and 60�C for 60 s. The
study was explained to participants and written informed con-
sent was subsequently obtained. The study protocol was ap-
proved by the Human Research Governance Committee at
C© 2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim www.mnf-journal.com
1908 S. Saha et al. Mol. Nutr. Food Res. 2012, 56, 1906–1916
the Institute of Food Research and Norwich Research Ethics
Committee (LREC 2003/082).
The study was a randomized two-phase crossover design
investigating the bioavailability of phytochemicals from fresh
and processed broccoli in subjects of known GSTM1 geno-
type. Each of the two test phases comprised a 5-day period
of intervention separated by a washout period of at least
1 week. During each period of intervention, subjects followed
a cruciferous vegetable-free diet. To aid compliance, a list of
authorized and prohibited foods was provided to volunteers.
On day 3 of the intervention, subjects arrived at the Human
Nutrition Unit following an overnight fast and an intravenous
catheter was inserted. A baseline blood sample was obtained.
Subjects were given a standard breakfast consisting of two
slices of white toast with spread prior to ingesting a cold broc-
coli soup that had been prepared either from lightly cooked
fresh broccoli (100 g fresh weight) or frozen broccoli (100 g)
(see below). The volunteers were blinded to the intervention
meal. Blood samples (10 mL) were collected into lithium hep-
arin tubes at 15, 30 and 45 min and 1, 1.5, 2, 3, 4, 6, 8, 24 and
48 h after broccoli consumption. Blood was immediately cen-
trifuged at 2000 × g (10 min at 4�C) and samples of the plasma
acidified with HCl. Urine was collected the day before con-
sumption of broccoli (24-h collection) and between 0–2, 2–4,
4–6, 6–8, 8–24 and 24–48 h after consumption. The amount
of urine from each period was measured and subsamples
were acidified with HCl. All plasma and urine samples were
subsequently stored at −80�C until analysis.
2.3 Broccoli cultivation and preparation
Broccoli (cultivar Marathon) was grown at the ADAS Experi-
mental Research Station (Terrington, Norfolk, UK) and har-
vested in September 2005. One half of the harvested broccoli
was used fresh (within 24 h of harvesting from the field)
while the other half was processed at a commercial vegetable
processing factory (Christian Salvesen, Bourne, Lincolnshire,
UK) as follows: blanching (91.2�C × 140 s), blast freezing
(−33�C), storage (−28�C). For both fresh and frozen broccoli,
individual soups were prepared by cooking 100 g broccoli flo-
rets (pre-thawed in case of frozen material) with 150 g water
for 75 s in a microwave oven on full power (700 W), followed
by homogenisation in a domestic food blender. For each of
the fresh and frozen broccoli soups, the individual soup por-
tions were combined, mixed and individual portions (235 g)
frozen in bags. Broccoli soups were kept frozen (−18�C) until
use. For the interventions, soups were thawed overnight in
a fridge and consumed without further processing. Samples
of each soup type were taken for analysis of glucosinolates,
isothiocyanate and nitrile.
To investigate the effects of cooking broccoli on the po-
tential for sulforaphane production, a large batch (20 kg) of
broccoli was purchased from a local supermarket, washed in
water and cut into small florets (3–4 cm). Individual sam-
ples (200 g fresh weight) were subjected to steaming (florets
cooked in pre-heated domestic steamer), or boiling (florets
added to pan of boiling water with enough water to just cover
florets) or microwave cooking (in a bowl with 50 g water on
700 watts full power) for 0, 0.25, 0.50, 0.75, 1.0, 1.5, 2, 3, 4, 5 or
7 min. Immediately after the cooking period had ended, the
broccoli tissue was cooled using dry ice and frozen (−20�C).
After freeze-drying and milling, samples were analysed
for glucosinolates, isothiocyanate and nitrile as described
below.
2.4 Analysis of glucosinolates, isothiocyanate,
and nitrile in broccoli
Broccoli tissue and soups were freeze-dried and powdered
(domestic food mixer) prior to analysis. All samples were
extracted and analysed in triplicate. Broccoli glucosinolates
were measured using a method that converts the glucosi-
nolates to the equivalent desulfoglucosinolates [12]. Briefly,
Samples (100–200 mg) of broccoli powder were extracted with
hot aqueous methanol (70% vol/vol, 5 mL) following the ad-
dition of internal standard (sinigrin). Samples were mixed
by vortexing and incubated at 70�C for 20–30 min with oc-
casional mixing. Extracts were allowed to cool and a sample
(3 mL) of the supernatant was applied to an ion exchange
column that was subsequently washed with water (2 × 0.5
mL) and then 0.02 M sodium acetate (2 × 0.5 mL). The
columns were then layered with purified sulfatase (75 �L)
and incubated at RTP overnight. The desulfoglucosinolates
were eluted by sequential application of 0.5, 0.5, and 0.25 mL
water and analysed using HPLC as described below.
Glucosinolate breakdown products (isothiocyanate and ni-
trile) were measured in samples of broccoli powder that had
been dissolved in buffer to facilitate the action of endoge-
nous enzymes (myrosinase) and cofactors (ESP). Samples
(40 mg) of freeze-dried broccoli powder were thoroughly
mixed with phosphate-buffered saline (Invitrogen, Paisley,
UK). The tubes were sealed and vortex mixed. The samples
were incubated on the heating block at 37�C for 2 h, with
vortex mixing every 15 min to ensure optimal hydrolysis. The
tubes were centrifuged (13 000 × g, 4�C for 30 min) and the
supernatants were removed and filtered (0.2 �m) and anal-
ysed by HPLC as described below.
Desulfoglucosinolates were analysed using a Waters
Spherisorb ODS2 (250 × 4.6 mm id, 5 �m particle size)
column connected to a model 1100 HPLC system (Agilent
Technologies, Waldbronn, Germany) comprising of a binary
pump, degasser, cooled autosampler, column oven and diode
array detector. Samples were eluted at 1.0 mL/min with a
gradient of increasing ACN using water (solvent A) and ACN
(solvent B). The gradient started at 0% solution B increas-
ing over 25 min to 50% B and finally re-equilibrated to 0%
B for 13 min. Desulfoglucosinolates were monitored at 229.
Glucoraphanin was detected in the broccoli and soups but
glucoerucin was not detected in the broccoli and soups. Glu-
coraphanin was quantified using absorbance at 229 nm by
C© 2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim www.mnf-journal.com
Mol. Nutr. Food Res. 2012, 56, 1906–1916 1909
comparison with the internal standard (sinigrin) peak area
ratio and with the correction factor (1.13) of the desulfoglu-
coraphanin [12]. Glucosinolate breakdown products (isothio-
cyanate and nitrile) were analysed using a Phenomenex Luna
C-18(2) (150 × 3 mm id, 3 �m particle size) column con-
nected to an Agilent 1100 HPLC system as described above
but with an additional on-line mass spectrometric detector
(Agilent Technologies). Samples were eluted at 0.3 mL/min
with a gradient of increasing ACN using 0.1% aq. formic acid
(solvent A) and 0.1% formic acid in ACN (solvent B). The gra-
dient started at 0% solution B increasing over 30 min to 30%
B and finally re-equilibrated to 0% B for 10 min. Sulforaphane
was monitored using absorbance at 235 nm, and were quanti-
fied by comparison to external standard curves (linear regres-
sion coefficients >0.99). Sulforaphane-nitrile was monitored
using MS in full scan positive ion mode with electrospray ion-
isation and quantified using selected ion monitoring (m/z =
146) and quantified by external standard curve of authentic
sulforaphane-nitrile (R2> 0.99).
2.5 Analysis of sulforaphane and sulforaphane
conjugates in plasma and urine
Plasma and urine were analysed for sulforaphane and its
glutathione, cysteine-glycine, cysteine and N-acetyl-cysteine
conjugates using a novel, validated method that has been
described recently [6]. Each sulforaphane conjugate was syn-
thesized and purified for use in this study as described previ-
ously [3].
2.6 Analyses of erucin conjugate in urine
Erucin N-acetyl-cysteine conjugate was synthesized by anal-
ogy with the procedure of Kassanhun et al. [3] for
sulforaphane–N-acetyl-cysteine. Hence erucin was added to a
solution of N-acetyl-cysteine, pre-adjusted to pH 7.8, in aque-
ous ethanol, it was purified by reversed-phase HPLC. Urine
samples (1 mL) were acidified to pH 4 with formic acid,
centrifuged at 13 000 × g for 10 min, filtered by (0.45 �m)
polypropylene syringe filter and 100 �L samples were injected
directly onto the HPLC column.
Erucin N-acetyl-cysteine was analysed using a Phe-
nomenex Luna C-18(2) (150 × 3 mm id, 3 �m particle size)
column connected to an Agilent 1100 HPLC system as de-
scribed above with an additional on-line mass spectromet-
ric detector (LC/MSD SL, Agilent Technologies) was added.
Samples were eluted at 0.3 mL/min with a gradient of in-
creasing ACN using 0.1% aq. formic acid (solvent A) and
0.1% formic acid in ACN (solvent B). The gradient started at
0% solution B increasing over 12 min to 50% B and finally re-
equilibrated to 0% B for 8 min. Erucin N-acetyl-cysteine was
monitored using MS in full scan positive ion mode with elec-
trospray ionisation. Identification was performed on the ba-
sis of retention time and spectra matching respect to spiking
synthetic standard in urine. Quantification was performed by
selected ion monitoring (m/z = 325) mode and spiking stan-
dard calibration curve of authentic erucin N-acetyl-cysteine.
(R2> 0.99).
2.7 Bioconversion of glucoraphanin by gut bacteria
The ability of the human gut microbiota to transform specific
glucosinolates was examined in a simple batch fermentation
model. The faecal inoculum was obtained from a healthy vol-
unteer who had not taken any antibiotics or pre- or probiotics
in the previous 2 months. The freshly voided faecal mate-
rial was homogenised (10% w/v) in 0.1M PBS (pH 7.0). One
millilitre of this slurry was then used to inoculate a vessel con-
taining 9 mL of pre-sterilised and pre-reduced basal growth
medium (peptone water 2 g/L, yeast extract 2 g/L, NaCl
0.1 g/L, K2HPO4 0.04 g/L, MgSO4.7H2O 0.01 g/L,
CaCl2.6H2O 0.01 g/L, NaHCO3 2 g/L, Tween-80 2 mL, hemin
0.02 g/L, vitamin K1 10 �L, cysteine HCl 0.5 g/L, bile salts 0.5
g/L, pH 7.0). The incubation was performed at 37�C under
oxygen-free atmosphere (10% H2; 10% CO2; 80% N2) using
an anaerobic cabinet (Don Whitley Scientific, Shipley, West
Yorkshire, UK). Glucosinolates were added to a final concen-
tration of 3 �g/mL. Samples (1 mL) were removed at intervals,
centrifuged at 12 000 × g for 5 min and the supernatants were
filter sterilised and stored at −20�C until further analysis. The
glucosinolate concentrations were analysed by HPLC using
pure glucosinolate standards glucoraphanin and glucoerucin.
Glucosinolates were isolated and purified following the pro-
cedure of Thies [13]. Rocket seed (Eruca sativa) was ground
to a fine powder (50 g) in a coffee grinder and then defat-
ted with petroleum ether (40–60�C fraction, 7 × 200 mL).
The defatted seed powder was extracted with boiling 80%
methanol for 20 min, filtered and the extraction repeated.
The combined filtrates were evaporated under reduced pres-
sure using a rotary evaporator. The residue was taken up in
water and treated with an equimolar mixture of barium and
lead acetate (0.5 M). The precipitate was removed by centrifu-
gation and added to a DEAE Sephadex A25 column (1.4 g)
pre-equilibriated with 6M imadazole formate. Following re-
peated washes with water, the column was cleaned with a
mixture of formic acid: isopropanol: water (3:2:5) and rinsed
with water. Glucosinolates were eluted with 0.5 M potassium
sulphate. Excess potassium sulphate was removed by mixing
the aqueous eluate with ethanol in a 1:1 ratio and removing
the precipitate by centrifugation. The supernatant was evap-
orated to near dryness and taken up in methanol and allowed
to stand at −20�C for 20 min and then centrifuged to re-
move the precipitate and the supernatant evaporated to give
a syrupy residue. The glucoerucin was then further purified
by chromatography on a Sephadex G10 equilibriated with wa-
ter. Glucoerucin elution was monitored at an absorbance of
230 nm and fractions freeze-dried to give the purified product
(400 mg). Purity was assessed by HPLC using a pure sinigrin
standard (Apin Chemicals UK).
C© 2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim www.mnf-journal.com
1910 S. Saha et al. Mol. Nutr. Food Res. 2012, 56, 1906–1916
Glucoraphanin was prepared following the procedure of
Iori et al. [14]. Hydrolysis products (1 mL) were extracted (X2)
with dichloromethane (1 mL) and the combined extracts dried
with anhydrous magnesium sulphate. The dichloromethane
extract was concentrated to 200 �L and analysed by GC-MS
as previously described [11].
2.8 Data analysis
Statistical analyses were performed using the R data analysis
software (R Development Core Team (2006). R: A language
and environment for statistical computing. R Foundation for
Statistical Computing, Vienna, Austria. ISBN 3–900051-07–0,
URL http://www.R-project.org.). Repeated Measures models
were used to analyse the data. For urine, “Total sulforaphane”
was the response and “Volunteer” was included as a “Random
Effect”. Plasma data were treated similarly but using different
response variables (Cmax, Tmax, AUC). For all models, re-
gression diagnostics were checked to determine if data trans-
formation, outlier omissions, or alternative non-parametric
models were required. All results from the models were con-
sidered significant if p < 0.05.
3 Results
3.1 Subjects
A total of 24 volunteers were genotyped in order to obtain
almost equal numbers of GSTM1 null (n = 10) and positive
(n = 8) subjects. In this rather limited sample (n = 24), the
prevalence of the GSTM1 null genotype was 66.6%, which is
within the range for Caucasians [15]. Eighteen subjects (16
females, two males) completed the entire study without re-
porting adverse events, and had the following anthropometric
characteristics (mean ± SD: age 45.1 ± 11.0 years; height
1.70 ± 0.07 m; weight 70.5 ± 12.1 kg; body mass index
25.7 ± 3.9 kg m–2).
3.2 Glucosinolates, sulforaphane, and sulforaphane
nitrile in soup
Analysis of the soups for glucosinolates, sulforaphane and
nitrile revealed that the soup made from lightly cooked fresh
broccoli contained significant quantities of sulforaphane
(4.16 mg per serving) but no glucosinolates; these data are
consistent with lightly cooked fresh broccoli retaining suffi-
cient myrosinase to hydrolyse all the glucoraphanin, part of
which is converted to sulforaphane. In contrast, the soups
made from commercially frozen broccoli contained signifi-
cant amounts of glucosinolates (18.6 mg per serving) but no
detectable sulforaphane, indicating complete loss of myrosi-
nase activity. These data show that the blanching process com-
pletely destroyed the myrosinase. Both soups contained small
quantities of sulforaphane nitrile (0.08 mg and 0.196 mg
for lightly cooked fresh and frozen broccoli, respectively).
3.3 Kinetics and bioavailability of sulforaphane
conjugates in urine and plasma
Before consumption of broccoli soups, sulforaphane and sul-
foraphane conjugates were not detected in samples of plasma
or urine from any of the volunteers. Following consumption
of the soups, sulforaphane and a range of thioconjugates
representing the entire mercapturic acid metabolic/excretory
pathway (Fig. 1) were detected and quantified. The order of
prevalence of the conjugates in plasma was sulforaphane
> sulforaphane-cysteine-glycine > sulforaphane-cysteine >
sulforaphane-glutathione ∼ sulforaphane-N-acetyl-cysteine.
The mean concentrations were as follows (lightly cooked from
fresh, lightly cooked from frozen broccoli soups, respectively)
sulforaphane (0.6194, 0.0336 �M), sulforaphane-cysteine-
glycine (0.4037, 0.0084 �M), sulforaphane-cysteine (0.1616,
0.0013 �M), sulforaphane-N-acetyl-cysteine (0.1229, 0.0031
�M) sulforaphane-glutathione (0.1151, 0.0004 �M). The or-
der of prevalence of the conjugates in urine was sulforaphane-
N-acetyl-cysteine > sulforaphane-cysteine > sulforaphane
> sulforaphane-cysteine-glycine > sulforaphane-glutathione.
The mean concentrations were as follows (lightly cooked
from fresh, lightly cooked from frozen broccoli soups,
respectively) sulforaphane-N-acetyl-cysteine (10.103, 1.680
�M), sulforaphane-cysteine (2.676, 0.445 �M), sulforaphane
(1.105, 0.136 �M), sulforaphane-cysteine-glycine (0.020,
0.001 �M) sulforaphane-glutathione (0.005, 0.000 �M).
When volunteers consumed a soup made from a stan-
dard portion of fresh broccoli that was lightly cooked, sul-
foraphane conjugates appeared in plasma within 15 min and
total conjugate concentrations peaked at 0.21 �M after 2 h
(Fig. 2A). After peaking, plasma levels declined to very low
levels (mean 0.5 nM) at 48 h. In contrast, when volunteers
consumed a soup made from frozen broccoli that had been
cooked in the same way, sulforaphane conjugates were not
detected in plasma until 1 h after consumption of the soup,
peaked much later at 6 h, and the maximal concentration
achieved in plasma was substantially lower (0.020 versus
0.21 �M, p for difference <0.0001; Fig. 2A). The rate of uri-
nary excretion (�mol total sulforaphane h−1) from the fresh
soup was highest in the 0–2 h collection and declined there-
after, whereas from the frozen broccoli soup the rate of excre-
tion peaked in the 4–6 h sample (Fig. 2B). Total urinary excre-
tion of sulforaphane from the lightly cooked fresh soup was
substantially and significantly higher than that for the lightly
cooked frozen soup (58.5% versus 9.6%; p for difference
< 0.0001). The pharmacokinetic parameters are shown in
Table 1.
Recently, we reported a significant difference between
GSTM1 positive and null genotypes in the urinary yield of
sulforaphane from an oral dose [16]. Accordingly, we strat-
ified our subjects according to GSTM1 genotype. However,
C© 2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim www.mnf-journal.com
Mol. Nutr. Food Res. 2012, 56, 1906–1916 1911
Figure 1. Structure of the broccoli
glucosinolate glucoraphanin, its break
down products sulforaphane (isothio-
cyanate) and sulforaphane-nitrile, and
the sulforaphane human metabolites
produced via the mercapturic acid
metabolic pathway.
there were no significant differences between the GSTM1
positive and null groups in either plasma pharmacokinetic
parameters (Cmax, Tmax, area under the curve) or total urinary
excretion (Table 1). Also, there were no significant differences
between the GSTM1 positive and null genotypes in the rela-
tive amounts of individual sulforaphane metabolites present
in plasma or urine (data not presented).
3.4 Effects of cooking broccoli
The complete lack of sulforaphane in the soups made from
commercial frozen broccoli that had been cooked only briefly
(75 s) is likely to be due to the blanching step used during
commercial freezing of broccoli. We investigated the effects
of the cooking process and the cooking time on the poten-
tial for sulforaphane production through the action of resid-
ual endogenous broccoli thioglucosidase activity. Samples of
fresh broccoli yielded 50–60% of sulforaphane and 30–50% of
sulforaphane-nitrile (molar yields) upon hydrolysis of freeze-
dried tissue in buffer. When cooked by boiling, sulforaphane
molar yields remained largely unaltered for the first 1.5 min
and then declined, while sulforaphane nitrile molar yields
were less than 5% for all of the cooked samples. Using a
microwave, sulforaphane molar yields increased to 80% at
75 s and then declined to 30% at 3 min and less than 6%
thereafter, while nitrile yields remained near 50% for up to
45 s before declining rapidly to less than 10% after 75 s.
Steamed broccoli retained high molar yields (>60%) up to
2 min before they declined rapidly; nitrile yields remained
above 30% up to 75 s before declining rapidly. These data
indicate that the best cooking methods for time-dependent
retention of sulforaphane production in broccoli are steam-
ing and microwave cooking. Broccoli boiled for just 2 min
generated less than 15% mole yield of sulforaphane from
glucoraphanin.
3.5 Erucin N-acetyl-cysteine in urine
To assess the possibility of sulforaphane and erucin inter-
conversion, six urine samples were analysed for the presence
of erucin N-acetyl-cysteine conjugate (the major metabolite
in urine) from three volunteers following consumption of
either the lightly cooked or frozen broccoli. In each case,
this compound could be detected. The pharmacokinetics of
erucin was not similar to that of sulforaphane. The rate
of urinary excretion (�mols) from the lightly cooked fresh
soup was highest in the 4–6 h collection period and declined
thereafter, whereas from the lightly cooked frozen broccoli
soup, the rate of excretion peaked in the 8–24 h (see Fig. 3).
The ratio of erucin N-acetyl-cysteine and sulforaphane N-
acetyl-cysteine was similar in between subjects (three sub-
jects) in lightly cooked fresh broccoli consumption group
C© 2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim www.mnf-journal.com
1912 S. Saha et al. Mol. Nutr. Food Res. 2012, 56, 1906–1916
Figure 2. Plasma pharmacokinetic profiles (A) and urinary excre-
tion rates (B) following consumption of broccoli florets that were
lightly cooked from fresh (filled circles and bars) or from frozen
(open circles and bars). The lightly cooked fresh broccoli soup
contained 23.5 �moles of sulforaphane and no glucoraphanin;
the lightly cooked frozen broccoli soup contained 42.5 �moles of
glucoraphanin and no sulforaphane.
but variable in frozen broccoli consumption group (Table 2).
The sulforaphane N-acetyl-cysteine was approximately three
times higher than erucin N-acetyl-cysteine in both groups
(Table 2).
3.6 Bioconversion of glucoraphanin to glucoerucin
in the human gut
Glucoerucin is the major glucosinolate in Rocket seeds [14]
providing a convenient source of material in good yields.
In order to obtain glucoraphanin, the reduced form of glu-
coerucin was oxidised with hydrogen peroxide followed by
purification on DEAE-A25 Sephadex and Sephadex G10. The
bioconversion of glucoraphanin in a simple batch fermenta-
tion model of human gut microbiota was followed by HPLC
and GC-MS analysis (Fig. 4). The time course curve (Fig. 4C)
shows that the glucoraphanin concentration remained near
the initial concentration at the 4-h sample point and then de-
creased dramatically in the 8 and 24 h samples. Glucoerucin
was not detected at the 0- and 4-h sample points but appeared
in appreciable concentrations in the 8 and 24 h samples.
The hydrolysis products at each time point were analysed by
GC-MS, and product formation was observed only in the 8
and 24 h samples. Erucin, erucin-nitrile, sulforaphane and
sulforaphane-nitrile were all detected in the 24 h sample
(Table 3). However, no hydrolysis products were detected
in the 0 and 4 h samples while only erucin nitrile was de-
tected in the 8 h sample. The peak abundances for erucin
(28.06%) and erucin-nitrile (68.53%) were much higher than
for sulforaphane and sulforaphane-nitrile where only trace
amounts were detected (Table 3). No glucoerucin or gluco-
raphanin breakdown products (sulforaphane, sulforaphane
nitrile, erucin and erucin nitrile) were detected in incubations
conducted with autoclave-sterilised faecal samples indicating
that the origins of the reduction of glucoerucin and hydrolysis
products are entirely enzymatic.
4 Discussion
4.1 Bioavailability
Epidemiological evidence consistently supports a link be-
tween increased cruciferous vegetable consumption and re-
duced risk of cancer at several sites [17]. Sulforaphane,
the isothiocyanate released from glucoraphanin, has at-
tracted particular interest for its anticarcinogenic effect. Sul-
foraphane was present predominantly as free sulforaphane
in plasma (see results section 3.3, Fig. 2A) but also as a num-
ber of conjugates (glutathione, cysteine-glycine, cysteine, N-
acetyl-cysteine) [6]. Here, we report that consumption of a
standard portion of lightly cooked broccoli provides a reason-
able dose of sulforaphane (100 �M in soup; 23.5 �mol), and
leads to the rapid appearance in plasma of a number of thiol-
conjugates that are subsequently excreted via the urine. These
data are mainly consistent with a report describing the plasma
pharmacokinetics and urinary excretion of sulforaphane fol-
lowing consumption of a soup made from standard broccoli,
and a soup made from broccoli with enhanced levels of sul-
foraphane [16]. Further, none of our subjects excreted all the
ingested sulforaphane; mean urinary sulforaphane excretion
was 58.5% of dose and the highest individual urinary yield
was 79.6%. The reasons for the differences in urinary yield
between this study and that reported previously [16] are not
clear, but it is plausible that the different dosages are an im-
portant factor.
Broccoli is consumed largely as a cooked vegetable, al-
though a small proportion is eaten raw, for example when
used in salads. It has been established that extended cook-
ing of broccoli and other cruciferous vegetables inactivates
endogenous myrosinase enzyme activity and that as a con-
sequence, the glucosinolates enter the gastrointestinal tract
intact [2]. Shorter cooking times can lead to enhanced
C© 2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim www.mnf-journal.com
Mol. Nutr. Food Res. 2012, 56, 1906–1916 1913
Table 1. Comparison of plasma pharmacokinetic and urinary excretion data for the study population and stratified according to GSTM1
genotype
GSTM1-positive (n = 8) GSTM null (n = 10) p-valuea)
Broccoli type Genotype
Plasma sulforaphanec)
Cmax (�mol/L)
Fresh broccoli 0.271 ± 0.127b) 0.224 ± 0.140 <0.0001 0.45
Frozen broccoli 0.031 ± 0.030 0.021 ± 0.020
Tmax (h)
Fresh broccoli 1.47 ± 0.74 2.13 ± 1.01 <0.0001 0.39
Frozen broccoli 9.14 ± 6.72 7.00 ± 1.07
AUC (�mol h/L)
Fresh broccoli 1.26 ± 0.80 1.27 ± 0.96 <0.0006 0.61
Frozen broccoli 0.414 ± 0.576 0.144 ± 0.131
Urinary sulforaphanec)
Total urinary excretion (0–48 h) (�mol)
Fresh broccoli 13.39 ± 1.52 14.03 ± 2.93 <0.0001 0.35
Frozen broccoli 1.90 ± 0.62 2.55 ± 0.99
a) Derived using ANCOVA model.b) Data presented as mean ± standard deviation.c) “Sulforaphane” values represent the combined total of free sulforaphane plus the glutathione, cysteine-glycine, cysteine and N-acetyl-cysteine conjugates.Volunteers consumed the broccoli as a soup in a single seating. The lightly cooked fresh broccoli soup contained 23.5 �moles of sul-foraphane and no glucoraphanin; the lightly cooked frozen broccoli soup contained 42.5 �moles of glucoraphanin and no sulforaphane.
Figure 3. Urinary excretion of erucin-N-acetyl-cysteine after con-
sumption of fresh (black bar) and frozen (grey bar) broccoli soup.
Urine was collected for the time periods indicated and the con-
tent of erucin-N-acetyl-cysteine quantified using LC-MS. Data are
average for three subjects with error bars indicating the SD.
isothiocyanate production due to destruction of ESP that
appears to be responsible for the conversion of the un-
stable thiohydroxamate-O-sulfonate to isothiocyanate-nitriles
[2]. We were interested in establishing the isothiocyanate ex-
posure derived from standard portions of typical, commer-
cially available broccoli. Broccoli is almost exclusively avail-
able to the consumer in two forms–fresh broccoli heads and
frozen broccoli florets. In this report, we show that while
light cooking of fresh broccoli facilitated the production of
significant quantities of sulforaphane upon maceration of
the broccoli, frozen broccoli, when cooked in the same man-
ner, generated no sulforaphane. Further, when the subjects
consumed soups made from lightly cooked fresh broccoli, up
to 80% of the sulforaphane was excreted in urine and the
concentrations in plasma reached 0.21 �M (mean for 18
subjects). In contrast, when the volunteers consumed soups
made with lightly cooked frozen broccoli, only a small fraction
Table 2. Sulforaphane N-acetyl cysteine and erucin N-acetyl-cysteine urinary excretion after consumption of soups made with lightly
cooked fresh and frozen broccoli
Subject Total Total Ratio (total erucin-NAC/total
sulforaphane-NACa) erucin-NAC sulforaphane-NAC)
Fresh broccoli
(�moles)
Frozen broccoli
(�moles)
Fresh broccoli
(�moles)
Frozen broccoli
(�moles)
Fresh broccoli Frozen broccoli
1 8.3 1.1 2.4 0.39 0.29 0.35
2 10.5 1.3 3.6 0.68 0.34 0.52
3 6.6 1.5 2.3 0.38 0.35 0.25
Mean 8.5 1.3 2.8 0.48 0.33 0.38
a) NAC, N-acetyl cysteine conjugate.
C© 2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim www.mnf-journal.com
1914 S. Saha et al. Mol. Nutr. Food Res. 2012, 56, 1906–1916
Figure 4. Conversion of glucoraphanin to glucoerucin in a simple
batch fermentation model. Glucoraphanin (starting concentration
6.3 nmoles/mL) was added to a basal growth medium that had
been inoculated with human faecal slurry and incubated at 37�C.
Samples were removed at the indicated time points and analysed
for glucoraphanin and glucoerucin by HPLC. The chromatogram
(A) is shown for glucosinolate analysis at 8-h sample, the chro-
matogram (B) is shown for glucosinolate analysis at 24-h sample
and the time course curve is shown in (C).
of the glucoraphanin was excreted in urine as sulforaphane
(≈5% on average) and mean plasma concentrations peaked
at 0.025 �M (Fig. 2). A number of reports concerned with
the effects of cooking broccoli on sulforaphane production
have been published. Shapiro et al. reported that the to-
tal urinary excretion of isothiocyanates from fresh broccoli
sprouts was about sixfold higher than for an equivalent dose
of cooked broccoli sprouts [18]. Conaway et al. reported that
steaming reduced the mean plasma concentrations and uri-
nary excretion of sulforaphane from broccoli significantly [7].
Vermeulen et al. reported that consumption of raw broccoli
results in faster absorption, higher bioavailability and higher
concentration of sulforaphane compared to cooked broccoli in
urine and plasma samples [19]. Hence, domestic processing
is a major factor determining the exposure to isothiocyanates
from cruciferous vegetable consumption. Our data show that
commercial frozen broccoli lacks the thio-glucosidase activ-
ity required for sulforaphane generation and, as a result, only
glucosinolates are delivered to the gastrointestinal tract. We
observed that the appearance and peak of sulforaphane in
plasma occurred later than for lightly cooked fresh broc-
coli, presumably because intestinal microflora provide the
thio-glucosidase activity required for sulforaphane produc-
tion, and absorption cannot occur in the stomach/small in-
testine. These data suggest that the efficiency of sulforaphane
absorption from glucosinolates delivered to the colon is low
compared with sulforaphane delivered to the upper gastroin-
testinal tract. Since the majority of broccoli is cooked prior
to consumption, and in most cases for periods sufficiently
long to destroy myrosinase activity, the sulforaphane expo-
sure level for the vast majority of the population will be sim-
ilar to that reported here for frozen (cooked) broccoli (see
Fig. 2).
The lack of myrosinase activity in frozen broccoli not only
caused a substantial reduction in the amount of sulforaphane
absorbed and the resulting circulating concentrations (∼10-
fold lower in this study; see Fig. 2A), but also changed the site
of absorption, and this could have important effects on the
potential for bioactivity at these absorption sites. For fresh
and lightly cooked fresh broccoli, the oesophagus, stomach
and small intestine are exposed to the relatively high con-
centrations of sulforaphane released from the crushed broc-
coli through the action of the plant myrosinase (100 �M in
soup), whereas for frozen broccoli the direct exposure to sul-
foraphane would be extremely low. The cells of these upper
gastrointestinal tract tissues would be expected to take up
sulforaphane from fresh broccoli rapidly and accumulate sul-
foraphane and its glutathione conjugate at very high concen-
trations (several hundred micromolar), as has been reported
elsewhere for several cell types [20, 21]. For frozen broccoli,
the upper gastrointestinal tract would only be exposed to sul-
foraphane via the peripheral circulation, and in this case,
the exposure concentrations would be orders of magnitude
lower (20 nM in this study; Fig. 2A). Zhang and Talalay re-
ported that the ability of an isothiocyanate (ITC) to induce a
phase-2 enzyme (quinone reductase, QR) correlated with the
extent to which the ITC was taken up, accumulated and conju-
gated with glutathione when treating murine hepatoma cells
with micromolar concentrations of ITCs [20]. But, detectable
changes in QR induction were only observed concentration at
C© 2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim www.mnf-journal.com
Mol. Nutr. Food Res. 2012, 56, 1906–1916 1915
Table 3. Total ion currenta) of hydrolysis products from the incubation of glucoraphanin with a faecal slurry over 24 h
Hydrolysis product T = 0 h T = 4 h T = 8 h T = 24 h
Sulforaphane- ITC 0 0 0 6.24 (1.6)b)
Sulforaphane-nitrile 0 0 0 7.36 (1.9)b)
Erucin-ITC 0 0 0 111.76 (28.1)b)
Erucin-nitrile 0 0 11.9 (100)b) 272.94 (68.5)b)
a) Total ion current obtained by GC-MS analysis of dichloromethane extracts of the fermentation.b) Figures in parentheses show the proportion of hydrolysis products calculated from the total ion current obtained by GC-MS analysis ofdichloromethane extracts of the fermentation.
>0.2 �M, which is tenfold higher than the observed peak in
peripheral blood reported here following ingestion of frozen
broccoli (i.e. QR is not likely to be induced by frozen broccoli).
It was subsequently demonstrated that significant increases
in GSTA1 transcripts could be induced in vivo by perfusion
of the proximal jejunum with a solution containing 11 �M
sulforaphane [21]. Thus, the tissues of the upper gastroin-
testinal tract may benefit from the direct luminal exposure
to micromolar concentrations of sulforaphane delivered by
fresh broccoli, whereas sulforaphane from frozen broccoli is
only likely to influence the upper gastrointestinal tract tissues
via the peripheral circulation, with substantial differences in
the exposure concentrations. Nevertheless, peripheral expo-
sure to low concentrations of sulforaphane conjugates derived
from frozen broccoli can still induce significant changes in
gene expression of tissues, as recently demonstrated in the
prostate tissue of men with prostatic intraepithelial neoplasia
who had consumed frozen broccoli for 12 months [22].
In our study, we also looked at bioconversion of sul-
foraphane to its reduced analogue erucin, in human urine
samples. Urinary erucin N-acetyl-cysteine accounted for 10–
15% of ingested sulforaphane after consumption of lightly
cooked fresh broccoli soup and 1–2% after consumption of
lightly cooked frozen broccoli soup. Thus, the differences in
the yields of sulforaphane and erucin for frozen compared
to fresh broccoli were similar (∼10-fold lower). Interestingly,
our glucosinolate analyses did not confirm the presence of
glucoerucin in either the lightly cooked fresh or the frozen
broccoli soup. Erucin mercapturic acid in urine had been pre-
viously reported after consumption of cruciferous vegetables,
such as broccoli, red and white cabbage that do not contain
glucoerucin [23]. These results show that the reduction of the
sulfinyl group, changing sulforaphane into erucin, can take
place. This was also confirmed in rats by Kassahun et al. [3]
and Bheemreddy et al. [9] and in humans by Clarke et al. [10].
It is not clear what drives the conversion of the sulfoxide sul-
foraphane to the thioether erucin but this is an important
area for future study.
4.2 Bioconversion of glucoraphanin by human gut
microbiota
We investigated the ability of the human gut microbiota
to transform specific glucosinolates in a simple batch fer-
mentation model. Our time course study showed that gluco-
raphanin started to decrease beyond 4 h of incubation and
was substantially reduced after 24 h of incubation, and there
was a corresponding appearance of glucoerucin that was first
detected in 8 h samples and further increased after 24-h in-
cubation. The conversion of glucoraphanin to glucoerucin
did not occur with heat-sterilised samples, and this is the
first report of bioconversion of glucoraphanin to glucoerucin
by human gut microbiota. The formation of sulforaphane
by hydrolysis of glucoraphanin in the cecum of rats and
its ability to cross the cecal enterocyte for systemic absorp-
tion was reported by Lai et al. [24]. They also found very low
levels of the hydrolytic metabolite erucin nitrile by anaero-
bic incubation in rat cecal microbiota. It is known that the
unstable intermediate formed during glucosinolate hydroly-
sis can undergo non-enzymatic rearrangement to a nitrile.
In our study, erucin-nitrile was also detected in the faecal
flora incubations by MS and the abundance was higher than
erucin.
In conclusion, we have demonstrated that the peripheral
exposure to sulforaphane from a single serving of lightly
cooked fresh broccoli is around 0.2 �M, but that the expo-
sure derived from broccoli as it is typically consumed is about
10-fold lower. These physiological concentrations are below
those reported to cause a range of responses in cellular mod-
els. In this study, we reported that erucin-N-acetyl-cysteine
was detected in the urine sample after consumption of either
the lightly cooked form of fresh or frozen broccoli and the
bioavailability of erucin in urine dramatically lowered when
subjects consumed lightly cooked frozen broccoli soup com-
pared to lightly cooked fresh broccoli soup. Further evidence
in this study reported that glucoraphanin and glucoerucin
interconvert in the human microbiota.
The authors thank all the staff at the IFR Human Nutrition
Unit for their assistance with the study, and all our dedicated
volunteers who made the study possible. We also thank Jim Bacon
(IFR) for assistance with the genotyping and Jack Dainty for
assistance with the statistical analysis. We thank Tozer Seeds Ltd.
for their kind gift of Rocket seed. This work was funded by the
Food Standards Agency (UK) with additional support from the
Biotechnology and Biological Sciences Research Council (BBSRC
grant no. 42/D 20475 and 42/D1800) UK.
The authors have declared no conflict of interest.
C© 2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim www.mnf-journal.com
1916 S. Saha et al. Mol. Nutr. Food Res. 2012, 56, 1906–1916
5 References
[1] Kristal, A. R., Lampe, J. W., Brassica vegetables and prostate
cancer risk: a review of the epidemiological evidence. Nutr.
Cancer 2002, 42, 1–9.
[2] Matusheski, N. V., Juvik, J. A., Jeffery, E. H., Heating de-
creases epithiospecifier protein activity and increases sul-
foraphane formation in broccoli. Phytochemistry 2004, 65,
1273–1281.
[3] Kassahun, K., Davis, M., Hu, P., Martin, B. et al., Biotrans-
formation of the naturally occurring isothiocyanate sul-
foraphane in the rat: identification of phase I metabolites
and glutathione conjugates. Chem. Res. Toxicol. 1997, 10,
1228–1233.
[4] Ye, L., Dinkova-Kostova, A. T., Wade, K. L., Zhang, Y. et al.,
Quantitative determination of dithiocarbamates in human
plasma, serum, erythrocytes and urine: pharmacokinetics of
broccoli sprout isothiocyanates in humans. Clin. Chim. Acta.
2002, 316, 43–53.
[5] Kristensen, M., Krogholm, K. S., Frederiksen, H., Duus, F.
et al., Improved synthesis methods of standards used for
quantitative determination of total isothiocyanates from
broccoli in human urine. J. Chromatogr. B Analyt. Technol.
Biomed. Life Sci. 2007, 852, 229–234.
[6] Al Janobi, A. A., Mithen, R. F., Gasper, A. V., Shaw, P. N. et al.,
Quantitative measurement of sulforaphane, iberin and their
mercapturic acid pathway metabolites in human plasma and
urine using liquid chromatography-tandem electrospray ion-
isation mass spectrometry. J. Chromatogr. B Analyt. Technol.
Biomed Life Sci. 2006, 223–234.
[7] Conaway, C. C., Getahun, S. M., Liebes, L. L., Pusateri, D.
J. et al., Disposition of glucosinolates and sulforaphane in
humans after ingestion of steamed and fresh broccoli. Nutr.
Cancer 2000, 38, 168–178.
[8] Melchini, A., Traka, M. H., Biological profile of erucin: a
new promising anticancer agent from cruciferous vegeta-
bles. Toxins 2010, 2, 593–612.
[9] Bheemreddy, R. M., Jeffery, E. H., The metabolic fate of pu-
rified glucoraphanin in F344 rats. J. Agric. Food Chem. 2007,
55, 2861–2866.
[10] Clarke, J. D., Hsu, A., Riedl, K., Bella, D. et al., Bioavailability
and inter-conversion of sulforaphane and erucin in human
subjects consuming broccoli sprouts or broccoli supplement
in a cross-over study design. Pharmacol. Res. 2011, 64, 456–
463.
[11] Zabala, M. d. T., Grant, M., Bones, A. M., Bennett, R. et al.,
Characterisation of recombinant epithiospecifier protein and
its over-expression in Arabidopsis thaliana. Phytochemistry
2005, 66, 859–867.
[12] Magrath, R., Bano, F., Morgner, M., Parkin, I. et al., Genet-
ics of aliphatic glucosinolates. I. Side chain elongation in
Brassica napus and Arabidopsis thaliana. Heredity 1994, 72,
290–299.
[13] Thies, W., Isolation of sinigrin and glucotropaeolin from cru-
ciferous seeds. Fett Wissenschaft Technologie-Fat Sci. Tech-
nol. 1988, 90, 311–314.
[14] Iori, R., Bernardi, R., Gueyrard, D., Rollin, P. et al., Formation
of glucoraphanin by chemoselective oxidation of natural glu-
coerucin: a chemoenzymatic route to sulforaphane. Bioorg.
Medic. Chem. Lett. 1999, 9, 1047–1048.
[15] Cotton, S. C., Sharp, L., Little, J., Brockton, N., Glutathione
S-transferase polymorphisms and colorectal cancer: a HuGE
review. Am. J. Epidemiol. 2000, 151, 7–32.
[16] Gasper, A. V., Al-Janobi, A., Smith, J. A., Bacon, J. R.
et al., Glutathione S-transferase M1 polymorphism and
metabolism of sulforaphane from standard and high-
glucosinolate broccoli. Am. J. Clin. Nutr. 2005, 82, 1283–
1291.
[17] Bianchini, F., Vainio, H., Isothiocyanates in cancer prevention.
Drug Metab. Rev. 2004, 36, 655–667.
[18] Shapiro, T. A., Fahey, J. W., Wade, K. L., Stephenson, K. K.
et al., Chemoprotective glucosinolates and isothiocyanates
of broccoli sprouts: metabolism and excretion in humans.
Cancer Epidemiol. Biomarkers Prev. 2001, 10, 501–508.
[19] Vermeulen, M., Klopping-Ketelaars, I. W., van den Berg, R.,
Vaes, W. H., Bioavailability and kinetics of sulforaphane in
humans after consumption of cooked versus raw broccoli.
J. Agric. Food Chem. 2008, 56, 10505–10509.
[20] Zhang, Y. S., Talalay, P., Mechanism of differential potencies
of isothiocyanates as inducers of anticarcinogenic phase 2
enzymes. Cancer Res. 1998, 58, 4632–4639.
[21] Petri, N., Tannergren, C., Holst, B., Mellon, F. A. et al., Absorp-
tion/metabolism of sulforaphane and quercetin, and regula-
tion of phase II enzymes, in human jejunum in vivo. Drug.
Metab. Dispos. 2003, 31, 805–813.
[22] Traka, M., Gasper, A. V., Melchini, A., Bacon, J. R. et al.,
Broccoli consumption interacts with GSTM1 to perturb onco-
genic signalling pathways in the prostate. PLoS One 2008, 3,
e2568.
[23] Vermeulen, M., van den Berg, R., Freidig, A. P., van Bladeren,
P. J. et al., Association between consumption of cruciferous
vegetables and condiments and excretion in urine of isoth-
iocyanate mercapturic acids. J. Agric. Food Chem. 2006, 54,
5350–5358.
[24] Lai, R. H., Miller, M. J., Jeffery, E., Glucoraphanin hydroly-
sis by microbiota in the rat cecum results in sulforaphane
absorption. Food Funct. 2010, 1, 161–166.
C© 2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim www.mnf-journal.com